Paper Details

Paper Title

Infliximab as a second-line therapy for children with refractory Kawasaki disease: A systematic review and meta-analysis of randomized controlled trials.

Paper Journal Title

Br J Clin Pharmacol

Paper Citation Count

Paper Publication Year

2023

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Kristian Thorlund	McMaster University

1 - 1

Dataset	Description	Source Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link

1 - 15

Paper Details

Column Actions

Datasets